Inhibikase Therapeutics Inc

NASDAQ:IKT   3:43:49 PM EDT
0.75
-0.05 (-5.70%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)19.03M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.3 Million
Adjusted EPS-$0.19
See more estimates
10-Day MA$0.84
50-Day MA$0.91
200-Day MA$1.44
See more pivots

Inhibikase Therapeutics Inc Stock, NASDAQ:IKT

3350 Riverwood Parkway, Suite 1900, Atlanta, Georgia 30339
United States of America
Phone: +1.678.392.3419
Number of Employees: 6

Description

Inhibikase Therapeutics, Inc. provides infectious disease treatments. It develops small molecule platform for treating both bacterial and viral infectious diseases. It operates through RAMPâ„¢ Drug Innovation Engine technology. The company was founded by Milton H. Werner in September 2008 and is headquartered in Atlanta, GA.